Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Elisabeth K. Degenhardt, MSN
JCP
Letter to the Editor
Reply to Pharmacokinetic Drug-Drug Interactions Between Olanzapine and Valproate Need to Be Better Studied
July 15, 2010
Terence A. Ketter
,
Mauricio Tohen
,
John P. Houston
, et al
JCP
Original Research
Olanzapine-Divalproex Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed Episodes: A Double-Blind, Placebo-Controlled Study
September 22, 2009
Terence A. Ketter
,
Mauricio Tohen
,
John P. Houston
, et al
PCC
Letter to the Editor
Olanzapine for the Treatment of Bipolar Disorder
June 1, 2002
Elisabeth K. Degenhardt
,
Saeeduddin Ahmed
,
Hillary C. McGuire
